高级检索

    Palbociclib 联合来曲唑一线治疗ER阳性、HER2阴性进展期乳腺癌能显著提高无进展生存期

    Palbociclib in Combination with Letrozole Versus Letrozole alone as First-Line Treatment of Oestrogen Receptor Positive, HER2-Negative, Advanced Breast Cancer Significantly Improve Progression-Free Survivial

      摘要
      • HTML全文
      • 参考文献(0)
      • 相关文章
      • 施引文献
    • 资源附件(0)

    /

    返回文章
    返回